摘要 |
<p>The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and/or antagonist biological activity: and wherein the variables Y, R<SUP>4</SUP>, n, o, A, A<SUP>1</SUP>, A<SUP>2</SUP>, X, Z, R<SUP>1</SUP>, R<SUP>3</SUP>, R<SUP>2</SUP>, p, q and r are as defined in the specification. These compounds are useful for treating a disease or condition selected from the group consisting of glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, and wound healing</p> |